Indian authorities seize J&J Baby Powder in response to Reuters report
pharmafile | December 19, 2018 | News story | Research and Development | Cancer, India, J&J, JJ, asbestos, baby powder, regulation
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after Reuter’s revealed that the American firm had known its products contained cancer-causing asbestos since the 1970s.
India’s Central Drugs Standard Control Organization (CDSCO) took samples from samples from the firms Baddi plant in the state of Himachal Pradesh late on Tuesday.
Regional drug officer for the southern state of Telangana, Surendranath Sai said on Wednesday that he had also instructed officers to seize samples.
“On the basis of the news report, we are alerting staff to pick up samples. We will test them in a drug control lab here,” Said said to reuters. “We will take action accordingly. Certainly we are worried because millions of babies may be affected.”
The action comes after a Reuters’ investigation revealed that J&J had covered up reports that their Baby Powder contained asbestos since 1971.
In response J&J said that “Reuters article is one-sided, false and inflammatory,” as the company declared that “Johnson & Johnson’s baby powder is safe and asbestos-free.”
Louis Goss
Related Content
Geneos Therapeutics shares data from phase 1/2 trial for cancer vaccine
Geneos Therapeutics has announced that it has published positive safety, immunogenicity and efficacy data from …
Curve Therapeutics’ CSO publishes research on HIF inhibition for cancer treatment
Curve Therapeutics has announced that its chief scientific officer, Professor Ali Tavassoli has published research …
FDA approves J&J’s Opsynvi for PAH treatment
Johnson & Johnson (J&J) has announced that the US Food and Drug Administration (FDA) has …